Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

NCT00940225

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +50 more
Locations
  • Pinnacle Oncology of Arizona Scottsdale, Arizona, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 47 locations
View Trial Details
Completed

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

NCT04511533

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Gujarat Cancer and Research Institute Ahmedabad, Gujarat, India
  • Hemato Oncology Clinic Ahmedabad Pvt. Ltd Ahmedabad, Gujarat, India
  • Gujarat Hospital - Gastro & Vascular Centre Surat, Gujarat, India
  • Unity Trauma Center And ICU (Unity Hospital ) Surat, Gujarat, India
View all 15 locations
View Trial Details
Completed

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

NCT03490669

Conditions
Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +28 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • START MidWest Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center- Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center- Westchester Harrison, New York, United States
View Trial Details
Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

NCT04148937

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +52 more
Locations
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
View Trial Details
Completed

The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04818983

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hyogo Cancer Center Akashi, Japan
  • Asahikawa Medical University Hospital Asahikawa, Japan
  • National Hospital Organization Asahikawa Medical Center Asahikawa, Japan
  • Juntendo University Hospital Bunkyō City, Japan
View all 95 locations
View Trial Details

Related conditions